Cell-free expression of the outer membrane protein OprF of Pseudomonas aeruginosa for vaccine purposes.
Géraldine MayeuxLandry GayetLavinia LiguoriMarine OdierDonald K MartinSandra CortèsBeatrice SchaackJean-Luc LenormandPublished in: Life science alliance (2021)
Pseudomonas aeruginosa is the second-leading cause of nosocomial infections and pneumonia in hospitals. Because of its extraordinary capacity for developing resistance to antibiotics, treating infections by Pseudomonas is becoming a challenge, lengthening hospital stays, and increasing medical costs and mortality. The outer membrane protein OprF is a well-conserved and immunogenic porin playing an important role in quorum sensing and in biofilm formation. Here, we used a bacterial cell-free expression system to reconstitute OprF under its native forms in liposomes and we demonstrated that the resulting OprF proteoliposomes can be used as a fully functional recombinant vaccine against P. aeruginosa Remarkably, we showed that our system promotes the folding of OprF into its active open oligomerized state as well as the formation of mega-pores. Our approach thus represents an easy and efficient way for producing bacterial membrane antigens exposing native epitopes for vaccine purposes.
Keyphrases
- cell free
- biofilm formation
- pseudomonas aeruginosa
- acinetobacter baumannii
- cystic fibrosis
- poor prognosis
- staphylococcus aureus
- candida albicans
- healthcare
- circulating tumor
- binding protein
- escherichia coli
- minimally invasive
- drug delivery
- cardiovascular events
- transcription factor
- immune response
- long non coding rna
- type diabetes
- small molecule
- methicillin resistant staphylococcus aureus
- acute care
- risk factors
- intensive care unit
- drug resistant
- coronary artery disease
- dendritic cells
- drug release